The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, A. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,211
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Nagore, E., Insa, A., & Sanmart??n, O. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001040-00004 · Cited by 298
Ranson, M. R., Carmichael, J., O'Byrne, K., Stewart, S., Smith, D., & Howell, A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3185 · Cited by 293
Chemotherapy-Associated Palmar-Plantar Erythrodysesthesia Syndrome
LOKICH, J. J., & MOORE, C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-798 · Cited by 224
Markman, M., KENNEDY, A. W., Webster, K. D., Peterson, G., Kulp, B., & Belinson, J. L. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5921 · Cited by 155
Rifkin, R. M., Gregory, S. A., Mohrbacher, A. M., & Hussein, M. A. (2006) · Cancer · doi:10.1002/cncr.21662 · Cited by 136
Multiple Injections of Pegylated Liposomal Doxorubicin: Pharmacokinetics and Therapeutic Activity
Charrois, G. J. R., & Allen, T. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053413 · Cited by 136
Vail, D. M., Chun, R., Thamm, D. H., Garrett, L., Cooley, A. J., & Obradovich, J. E. (1998) · PubMed · Cited by 122
Jacobi, U., Waibler, E., Schulze, P., Sehouli, J., Oskay-Özcelik, G., Schmook, T., Sterry, W., & Lademann, J. M. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi204 · Cited by 114
Rose, P. G., Maxson, J. H., Fusco, N. L., Mossbruger, K., & Rodriguez, M. J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6272 · Cited by 108
The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer
Campos, S. M., Penson, R. T., Mays, A. R., Berkowitz, R. S., Fuller, A. F., Goodman, A., Matulonis, U. A., Muzikansky, A., & Seiden, M. V. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.5980 · Cited by 107
Amantea, M., Newman, M. S., Sullivan, T. M., et al. (1999) · Human & Experimental Toxicology · doi:10.1177/096032719901800103 · Cited by 65
Lorusso, D., Naldini, A., Testa, A. C., D’Agostino, G. R., Scambia, G., & Ferrandina, G. (2004) · Oncology · doi:10.1159/000081324 · Cited by 36
Self-citationSehouli, J., Oskay-Özcelik, G., Kuhne, J. F., Stengel, D., Hindenburg, H.-J., Klare, P., Heinrich, G., Schmalfeldt, B., Mertens, H., Camara, O., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl079 · Cited by 31
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
van der Meel, R., Fens, M. H. A. M., Vader, P., van Solinge, W. W., Eniola-Adefeso, O., & Schiffelers, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.049 · Cited by 482
Metadata
- Authors
- Lorusso, D., Di Stefano, A., Carone, V., Fagotti, A., Pisconti, S., & Scambia, G.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 18
- Issue
- 7
- Pages
- 1159-1164
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2135274807
- Cited by
- 265
- References
- 16
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.